NHS pharmacogenomics trial expands to 20 sites across England
20 GP practices across England are now participating in the PROGRESS trial, a research study designed to establish the feasibility of providing an NHS-wide pharmacogenomics service that identifies genetic changes associated with commonly prescribed drugs. Providing an update on the trial at the Clinical Pharmacy Congress (CPC), held in London on 9 May 2025, Vicky […]
Publication Details
- Journal
- Pharmaceutical journal/The pharmaceutical journal
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1211/pj.2025.1.358641
- Primary Topic
- Health and Medical Research Impacts
- Type
- article
- Field-Weighted Citation Impact
- 0.00